NovoCure Ltd (NVCR)

Latest Insider Confidence Score

2026Q1

55.2
Bullish

Company insider confidence (by quarter)

2016Q2 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
WFD Ventures Fund II, L.P. 10% Owner 19,006,064 Feb 21, 2017
Volati Ltd — 7,216,789 Aug 5, 2016
Perlhagen Gert L. Director 6,125,000 Mar 16, 2017
Pomona Capital VII, L.P. 10% Owner 2,741,925 Jun 27, 2017
Pomona Capital VII Fund Investors, L.P. 10% Owner 2,741,925 Jun 27, 2017

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 4, 2026 Mar 5, 2026 Leupin Nicolas Former Chief Medical Officer Sell 46.3 -1,100 -1.06% ✗ $14.6K
Mar 4, 2026 Mar 5, 2026 Cordova Ashley CEO Sell 42.5 -17,638 -4.01% ✗ $234.6K
Mar 3, 2026 Mar 5, 2026 Ben Arye Barak General Counsel Neutral 90.0 +50,125 26.06% ✗ -
Mar 3, 2026 Mar 5, 2026 Weinberg Uri Chf Medical and Innovation Ofr Sell 95.0 +43,713 19.56% ✗ $85.3K
Mar 3, 2026 Mar 5, 2026 Brackmann Christoph CFO Sell 95.0 +48,725 36.33% ✗ $85.3K
Mar 3, 2026 Mar 5, 2026 Leonard Frank X CEO Sell 95.0 +144,393 41.33% ✗ $74.6K
Mar 3, 2026 Mar 5, 2026 Paravasthu Mukund COO Sell 40.0 -3,511 -4.60% ✗ $667.2K
Mar 3, 2026 Mar 5, 2026 Puri Michal Nath Chief Human Resources Officer Sell 91.3 +39,000 24.03% ✗ $14.6K
Mar 3, 2026 Mar 5, 2026 DOYLE WILLIAM F Chair Sell 97.5 +328,397 100.00% ✗ $932.9K
Feb 27, 2026 Mar 3, 2026 Weinberg Uri Chf Medical and Innovation Ofr Sell 82.5 +2,259 1.02% ✗ $146.9K
Feb 27, 2026 Mar 3, 2026 Puri Michal Nath Chief Human Resources Officer Sell 48.8 -1,441 -0.88% ✗ $19.7K
Feb 27, 2026 Mar 3, 2026 Leonard Frank X CEO Sell 65.0 +1,655 0.48% ✗ $230.6K
Feb 27, 2026 Mar 3, 2026 Cordova Ashley CEO Sell 75.0 +2,639 0.60% ✗ $290.4K
Feb 28, 2026 Mar 3, 2026 Ben Arye Barak General Counsel Neutral 90.0 +17,755 10.17% ✗ -
Jan 11, 2026 Jan 12, 2026 Paravasthu Mukund COO Sell 46.3 -2,133 -2.65% ✗ $30.6K
Dec 31, 2025 Jan 8, 2026 Puri Michal Nath Chief Human Resources Officer Neutral 47.5 +1 0.00% ✗ -
Dec 31, 2025 Jan 8, 2026 Danziger Asaf Director Neutral 47.5 +1 0.00% ✗ -
Dec 31, 2025 Jan 8, 2026 Ben Arye Barak General Counsel Neutral 55.0 +108 0.06% ✗ -
Nov 4, 2025 Nov 4, 2025 Brackmann Christoph CFO Sell 42.5 -7,033 -4.98% ✗ $86K
Nov 1, 2025 Nov 4, 2025 Paravasthu Mukund COO Sell 46.3 -3,117 -3.73% ✗ $38.2K
Nov 1, 2025 Nov 4, 2025 Leonard Frank X EVP, Pres., Novocure Oncology Sell 51.3 -966 -0.28% ✗ $12.4K
Oct 31, 2025 Nov 4, 2025 Puri Michal Nath Chief Human Resources Officer Sell 52.5 -752 -0.46% ✗ $9.6K
Sep 5, 2025 Sep 8, 2025 Cordova Ashley CEO Buy 97.5 +81,550 22.91% ✗ $996.9K
Jul 29, 2025 Jul 30, 2025 Brackmann Christoph CFO Buy 95.0 +20,000 16.51% ✗ $231.8K
Jun 30, 2025 Jul 1, 2025 Puri Michal Nath Chief Human Resources Officer Neutral 67.5 +833 0.51% ✗ -
Jun 30, 2025 Jul 1, 2025 Leonard Frank X EVP, Pres., Novocure Oncology Neutral 60.0 +833 0.24% ✗ -
Jun 30, 2025 Jul 1, 2025 Danziger Asaf Director Neutral 60.0 +833 0.20% ✗ -
Jun 30, 2025 Jul 1, 2025 Cordova Ashley CEO Neutral 60.0 +833 0.23% ✗ -
Jun 30, 2025 Jul 1, 2025 Ben Arye Barak General Counsel Neutral 60.0 +769 0.44% ✗ -
Jun 4, 2025 Jun 6, 2025 LEUNG GABRIEL Director Neutral 90.0 +11,215 13.81% ✗ -
Jun 4, 2025 Jun 6, 2025 Stafford Kristin Director Neutral 90.0 +11,215 367.22% ✗ -
Jun 4, 2025 Jun 6, 2025 Madden Martin J. Director Neutral 52.5 - 0.00% ✗ -
Jun 4, 2025 Jun 6, 2025 HILLEMAN JERYL L Director Neutral 90.0 +11,215 200.59% ✗ -
Jun 4, 2025 Jun 6, 2025 Ocean Allyson J Director Neutral 90.0 +11,215 367.22% ✗ -
Jun 4, 2025 Jun 6, 2025 Scannell Timothy J Director Neutral 90.0 +11,215 186.36% ✗ -
Jun 4, 2025 Jun 6, 2025 Hung David Director Neutral 90.0 +11,215 91.96% ✗ -
Jun 4, 2025 Jun 6, 2025 VERNON W ANTHONY Director Neutral 85.0 +11,215 6.68% ✗ -
Jun 4, 2025 Jun 6, 2025 Leonard Frank X EVP, Pres., Novocure Oncology Neutral 90.0 +179,426 106.51% ✗ -
Jun 3, 2025 Jun 4, 2025 Stafford Kristin Director Sell 46.3 -999 -24.65% ✗ $17.3K
Jun 3, 2025 Jun 4, 2025 LEUNG GABRIEL Director Sell 46.3 -999 -1.21% ✗ $17.3K
Jun 3, 2025 Jun 4, 2025 Madden Martin J. Director Sell 46.3 -999 -5.08% ✗ $17.2K
Jun 3, 2025 Jun 4, 2025 Scannell Timothy J Director Sell 46.3 -999 -14.24% ✗ $17.3K
Jun 3, 2025 Jun 4, 2025 HILLEMAN JERYL L Director Sell 46.3 -999 -15.16% ✗ $17.2K
Jun 3, 2025 Jun 4, 2025 Ocean Allyson J Director Sell 46.3 -999 -24.65% ✗ $17.3K
Jun 3, 2025 Jun 4, 2025 VERNON W ANTHONY Director Sell 48.8 -999 -0.59% ✗ $17.3K
Jun 3, 2025 Jun 4, 2025 Hung David Director Sell 46.3 -999 -7.57% ✗ $17.3K
Jun 2, 2025 Jun 4, 2025 Leonard Frank X EVP, Pres., Novocure Oncology Sell 17.5 -30,196 -15.20% ✓ $528.4K
May 3, 2025 May 5, 2025 Paravasthu Mukund COO Sell 48.8 -592 -0.70% ✗ $10.6K
Mar 4, 2025 Mar 6, 2025 Brackmann Christoph CFO Neutral 90.0 +54,975 83.08% ✗ -
Mar 4, 2025 Mar 6, 2025 Leupin Nicolas Chief Medical Officer Neutral 90.0 +54,975 109.66% ✗ -
Mar 4, 2025 Mar 6, 2025 Ben Arye Barak General Counsel Neutral 90.0 +54,975 46.31% ✗ -
Mar 4, 2025 Mar 6, 2025 Puri Michal Nath Chief Human Resources Officer Neutral 90.0 +54,975 50.57% ✗ -
Mar 4, 2025 Mar 6, 2025 Weinberg Uri Chief Innovation Officer Neutral 90.0 +54,975 33.07% ✗ -
Mar 4, 2025 Mar 6, 2025 Leonard Frank X EVP, Pres., Novocure Oncology Neutral 90.0 +54,975 38.26% ✗ -
Mar 4, 2025 Mar 6, 2025 Paravasthu Mukund COO Neutral 90.0 +54,975 188.44% ✗ -
Mar 4, 2025 Mar 6, 2025 Cordova Ashley CEO Neutral 90.0 +151,181 74.11% ✗ -
Mar 3, 2025 Mar 4, 2025 Weinberg Uri Chief Innovation Officer Sell 52.5 -268 -0.16% ✗ $5.1K
Mar 3, 2025 Mar 4, 2025 Leonard Frank X EVP, Pres., Novocure Oncology Sell 46.3 -2,527 -1.73% ✗ $46.8K
Mar 3, 2025 Mar 4, 2025 Cordova Ashley CEO Sell 48.8 -2,053 -1.00% ✗ $38.1K
Mar 3, 2025 Mar 4, 2025 Paravasthu Mukund COO Sell 50.0 -250 -0.85% ✗ $4.6K
Feb 28, 2025 Mar 3, 2025 Weinberg Uri Chief Innovation Officer Sell 42.5 -4,637 -2.71% ✗ $86.9K
Feb 27, 2025 Mar 3, 2025 Cordova Ashley CEO Sell 40.0 -13,494 -6.15% ✗ $266.1K
Feb 27, 2025 Mar 3, 2025 Leonard Frank X EVP, Pres., Novocure Oncology Sell 40.0 -15,036 -9.33% ✗ $296.3K
Feb 27, 2025 Mar 3, 2025 Puri Michal Nath Chief Human Resources Officer Sell 46.3 -1,387 -1.26% ✗ $27.8K
Feb 27, 2025 Mar 3, 2025 Leupin Nicolas Chief Medical Officer Sell 46.3 -991 -1.94% ✗ $19.8K
Feb 27, 2025 Mar 3, 2025 Paravasthu Mukund COO Sell 46.3 -2,014 -6.41% ✗ $39.7K
Feb 28, 2025 Mar 3, 2025 Weinberg Uri Chief Innovation Officer Sell 22.5 -4,637 -2.71% ✗ $86.9K
Feb 27, 2025 Mar 3, 2025 Leupin Nicolas Chief Medical Officer Sell 26.3 -991 -1.94% ✗ $19.8K
Feb 27, 2025 Mar 3, 2025 Puri Michal Nath Chief Human Resources Officer Sell 26.3 -1,387 -1.26% ✗ $27.8K
Feb 27, 2025 Mar 3, 2025 Leonard Frank X EVP, Pres., Novocure Oncology Sell 20.0 -15,036 -9.33% ✗ $296.3K
Feb 27, 2025 Mar 3, 2025 Cordova Ashley CEO Sell 20.0 -13,494 -6.15% ✗ $266.1K
Feb 27, 2025 Mar 3, 2025 Paravasthu Mukund COO Sell 26.3 -2,014 -6.41% ✗ $39.7K
Jan 11, 2025 Jan 15, 2025 Paravasthu Mukund COO Sell 42.5 -2,160 -6.43% ✗ $57.9K
Jan 6, 2025 Brackmann Christoph CFO Neutral 52.5 - 0.00% ✗ -
Dec 31, 2024 Jan 3, 2025 Ben Arye Barak General Counsel Neutral 67.5 +669 0.57% ✗ -
Dec 31, 2024 Jan 3, 2025 Cordova Ashley CEO Neutral 55.0 +373 0.17% ✗ -
Dec 31, 2024 Jan 3, 2025 Danziger Asaf Director Neutral 90.0 +400,412 2629.45% ✗ -
Nov 2, 2024 Nov 6, 2024 Paravasthu Mukund COO Sell 90.0 +30,094 859.09% ✗ $734.2
Oct 31, 2024 Nov 4, 2024 Puri Michal Nath Chief Human Resources Officer Sell 48.8 -810 -0.73% ✗ $12.8K
Nov 1, 2024 Nov 4, 2024 Leonard Frank X EVP, Pres., Novocure Oncology Sell 52.5 -598 -0.37% ✗ $9.5K
Nov 1, 2024 Nov 4, 2024 Paravasthu Mukund COO Sell 47.5 -160 -4.37% ✗ $2.5K
Oct 9, 2024 Paravasthu Mukund COO Neutral 52.5 - 0.00% ✗ -
Jun 28, 2024 Aug 6, 2024 Ben Arye Barak General Counsel Neutral 67.5 +930 0.79% ✗ -
Jun 28, 2024 Aug 6, 2024 GROENHUYSEN WILHELMUS CM COO Neutral 60.0 +1,055 0.42% ✗ -
Jun 28, 2024 Aug 6, 2024 Danziger Asaf CEO Neutral 85.0 +1,239 8.86% ✗ -
Jun 28, 2024 Aug 6, 2024 Cordova Ashley CFO Neutral 67.5 +1,286 0.59% ✗ -
Jun 28, 2024 Aug 6, 2024 Leonard Frank X EVP, Pres., Novocure Oncology Neutral 77.5 +1,736 1.08% ✗ -
Jun 28, 2024 Aug 6, 2024 Puri Michal Nath Chief Human Resources Officer Neutral 77.5 +1,736 1.59% ✗ -
Aug 2, 2024 Aug 5, 2024 Cordova Ashley CFO Sell 51.3 -688 -0.31% ✗ $13.9K
Jun 5, 2024 Jun 7, 2024 GROENHUYSEN WILHELMUS CM COO Neutral 52.5 - 0.00% ✗ -
Jun 5, 2024 Jun 6, 2024 Ocean Allyson J Director Neutral 90.0 +4,053 100.00% ✗ -
Jun 5, 2024 Jun 6, 2024 Madden Martin J. Director Neutral 90.0 +4,053 25.95% ✗ -
Jun 5, 2024 Jun 6, 2024 Hung David Director Neutral 90.0 +4,053 44.34% ✗ -
Jun 5, 2024 Jun 6, 2024 Stafford Kristin Director Neutral 90.0 +4,053 100.00% ✗ -
Jun 4, 2024 Jun 6, 2024 VERNON W ANTHONY Director Sell 68.8 +3,089 0.93% ✗ $23K
Jun 4, 2024 Jun 6, 2024 Scannell Timothy J Director Sell 91.3 +3,089 39.32% ✗ $23K
Jun 4, 2024 Jun 6, 2024 LEUNG GABRIEL Director Sell 78.8 +3,089 1.95% ✗ $23K
Jun 5, 2024 Jun 6, 2024 HILLEMAN JERYL L Director Neutral 90.0 +4,053 159.76% ✗ -
Mar 1, 2024 Mar 5, 2024 GROENHUYSEN WILHELMUS CM COO Sell 42.5 -3,324 -1.31% ✗ $53.3K
Mar 1, 2024 Mar 5, 2024 Leonard Frank X EVP, Pres., Novocure Oncology Sell 46.3 -2,519 -1.55% ✗ $40.4K